The Weekly Summary

April 10th – April 16th                                 2017

In general news, the Trump administration accused Russia of being complicit with the Syrian nerve gas attack. North Korea tried to launch a provocative missile, but it exploded. Meanwhile, U.S. ships head to the Korean Peninsula. Also, the U.S. dropped the “Mother of All Bombs” on a cluster of ISIS hideouts in Eastern Afghanistan, sending a message to North Korea as China also sent warnings to Kim Jong-un. In the U.S., Neil Gorsuch became the ninth SCOTUS justice.

In healthcare business news, Bristol (BMY) sold for $470 Million rights to anti-eTau and anti-myostatin to Biogen (BIIB) and Roche respectively. Also, Innoviva (INVA) began cost cutting measures after an activist investor applied pressure.

From the FDA, Abbott (ABT) received a warning letter over St Jude pacemakers and ICD’s. Finally, Teva’s (TEVA) plant in China raised concerns with the agency as well.

This entry was posted in - The Weekly Summary. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *